Risk Assessment Report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)

This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en- PINACA.

Metadata
Provider: 
ECEC
URL: 
https://www.emcdda.europa.eu/publications/risk-assessments/mdmb-4en-pinaca_enhttps://www.emcdda.europa.eu/publications/risk-assessments/mdmb-4en-pinaca_en
Retrieved on: 
Saturday, March 13, 2021
Information
Tags: 
Designer drugs, European Monitoring Centre for Drugs and Drug Addiction, European Union, Cannabinoids, Risk, Articles
Summary
Key Points: 
  • This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en- PINACA.
  • The report is intended for policymakers and decision-makers in the institutions of the EU.
  • Explanatory note: In the interests of public health protection the EMCDDA is releasing this report before formal copy editing and page layout in the EMCDDA house style.
  • The final report will be available in due course.
Copyright: 
2021 EC. All Rights Reserved.